NOCC FUNDS OCRF'S 2011 PROGRAM OF EXCELLENCE GRANT RECIPIENT
The National Ovarian Cancer Coalition is pleased to announce the funding of the Ovarian Cancer Research Fund’s 2011 Program of Excellence Grant Recipient, Ruth Perets, MD, PhD.
Dr. Perets’ research focuses on attempting to identify the cell responsible for ovarian cancer. Recent studies suggest that many of the most aggressive ovarian cancers arise from the tip of the fallopian tube near the ovary rather than from the ovary itself. Microscopic analysis of the fallopian tubes from women with inherited ovarian cancer and who have mutations in the BRCA1 gene reveals early cancers and even pre-cancerous lesions in their fallopian tubes. The objective of Dr. Perets’ research is to test whether the fallopian tube is the origin site of ovarian cancer. Her findings should provide evidence for the hypothesis that fallopian tube cells are responsible for ovarian cancer and will therefore enable women with predisposition to ovarian cancer to undergo better preventive screening.
“The NOCC is proud to have the opportunity to fund such groundbreaking research,” says David Barley, NOCC’s CEO. “Due to the lack of screening tools for detection of early stage ovarian cancer, most ovarian cancer is diagnosed late, when prognosis is poor. But when diagnosed early, ovarian cancer is over 90 % treatable. That is why research like this is so important. Anything that may lead to early detection is key to increasing survival rates.”
“We are thrilled that the NOCC is sponsoring an OCRF research grant,” says Audra Moran, OCRF’s CEO. “It’s partnerships like these that enable us to fund cutting-edge ovarian cancer research.”
The Ovarian Cancer Research Fund’s Ann Schreiber Research Training Programs of Excellence provide funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research. Ann Schreiber, for whom this grant is named, was a distinguished public administrator. OCRF was founded by her husband, Sol Schreiber, to honor Ann and her courageous five-year battle with ovarian cancer.
Dr. Perets’ research is taking place at the Dana Farber Cancer Institute in Boston.